Related Experiment Video
Updated: Feb 7, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
MBNL2 dysfunction in outer radial glial cells is associated with disrupted corticogenesis in congenital myotonic
Thiéry De Serres-Bérard1, Maya L Gosztyla2, Grady Nguyen2
1Department of Medicine, Faculty of Medicine, Université Laval, Quebec City, QC, Canada; CERVO Brain Research Centre, Quebec City, QC, Canada; Regenerative Medicine Division, CHU de Québec-Université Laval Research center, Quebec City, QC, Canada.
Abstract:
Myotonic dystrophy type 1 (DM1) arises from toxic CUG-expanded DMPK transcripts that sequester Muscleblind-like (MBNL) proteins, yet how this molecular lesion perturbs brain development in congenital DM1 (CDM) remains unknown. Here, we identify an unanticipated developmental role for MBNL2 in outer radial glial cells, a progenitor population critical for cortical expansion. We demonstrate that MBNL2 is expressed in these cells both in vivo and in forebrain organoids derived from patient-specific human induced pluripotent stem cells (hiPSCs), rendering them particularly sensitive to MBNL2 titration. Using genome editing to excise the CTG repeats in the DMPK gene, we provide evidence that the expanded trinucleotide tract directly contributes to defective neuronal migration and impaired differentiation of late-born cortical neurons in CDM organoids. These findings redefine MBNL2 as a potential regulator of human corticogenesis and uncover a developmental mechanism by which RNA toxicity drives this severe form of DM1. By revealing a prenatal origin for CDM neuropathology linked to MBNL2 dysfunction, this work opens avenues for therapeutic strategies targeting early developmental windows.
Insights
Congenital myotonic dystrophy type 1 (DM1) disrupts brain development by affecting MBNL2 protein in crucial progenitor cells. This study reveals MBNL2’s role in corticogenesis, offering new therapeutic targets for DM1.
Area of Science:
- Neuroscience
- Developmental Biology
- Genetics
Background:
- Myotonic dystrophy type 1 (DM1) is caused by toxic CUG-expanded DMPK transcripts.
- These transcripts sequester Muscleblind-like (MBNL) proteins.
- The impact on brain development in congenital DM1 (CDM) is largely unknown.
Purpose of the Study:
- To investigate the role of MBNL2 in brain development in congenital DM1.
- To identify the molecular mechanisms underlying CDM neuropathology.
- To explore MBNL2 as a potential therapeutic target.
Main Methods:
- Utilized patient-specific human induced pluripotent stem cells (hiPSCs) to generate forebrain organoids.
- Employed genome editing to excise CTG repeats in the DMPK gene.
- Assessed MBNL2 expression and function in outer radial glial cells.
Main Results:
- Identified a novel role for MBNL2 in outer radial glial cells, critical for cortical expansion.
- Demonstrated MBNL2 sensitivity in these progenitor cells.
- Showed that expanded trinucleotide repeats directly cause defective neuronal migration and differentiation in CDM organoids.
Conclusions:
- MBNL2 is a potential regulator of human corticogenesis.
- RNA toxicity and MBNL2 dysfunction contribute to CDM neuropathology.
- This research opens avenues for therapeutic strategies targeting early developmental windows in DM1.
Related Concept Videos
Glial Cells
Satellite Stem Cells and Muscular Dystrophy
Outer Layers of the Cell Envelope
Nervous Tissue: Glial Cells
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
Radial System Protection
In a radial system with a fault downstream of the third breaker, ideally, only the third breaker will open, isolating the fault and interrupting the load connected beyond it. The second breaker has a longer delay setting,...
Assessment of radial pulse
The radial pulse, located at the wrist, is often the preferred site for assessing peripheral pulse because of its accessibility and dependability. The process of determining the radial pulse involves several steps:

